Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP337752.RA1EYWyjFl08edMONcYPJcwWPmmgQThoa2gsi4TOTIXnk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP337752.RA1EYWyjFl08edMONcYPJcwWPmmgQThoa2gsi4TOTIXnk130_assertion type Assertion NP337752.RA1EYWyjFl08edMONcYPJcwWPmmgQThoa2gsi4TOTIXnk130_head.
- NP337752.RA1EYWyjFl08edMONcYPJcwWPmmgQThoa2gsi4TOTIXnk130_assertion description "[The percentages of CD4(+)CD25(+) T lymphocytes in pleural effusion and peripheral blood from patients with lung cancer with malignant effusion, pleural lavage and peripheral blood from patients with lung cancer without effusion, and peripheral blood from healthy control subjects were determined by flow cytometry.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP337752.RA1EYWyjFl08edMONcYPJcwWPmmgQThoa2gsi4TOTIXnk130_provenance.
- NP337752.RA1EYWyjFl08edMONcYPJcwWPmmgQThoa2gsi4TOTIXnk130_assertion evidence source_evidence_literature NP337752.RA1EYWyjFl08edMONcYPJcwWPmmgQThoa2gsi4TOTIXnk130_provenance.
- NP337752.RA1EYWyjFl08edMONcYPJcwWPmmgQThoa2gsi4TOTIXnk130_assertion SIO_000772 16151041 NP337752.RA1EYWyjFl08edMONcYPJcwWPmmgQThoa2gsi4TOTIXnk130_provenance.
- NP337752.RA1EYWyjFl08edMONcYPJcwWPmmgQThoa2gsi4TOTIXnk130_assertion wasDerivedFrom befree-20140225 NP337752.RA1EYWyjFl08edMONcYPJcwWPmmgQThoa2gsi4TOTIXnk130_provenance.
- NP337752.RA1EYWyjFl08edMONcYPJcwWPmmgQThoa2gsi4TOTIXnk130_assertion wasGeneratedBy ECO_0000203 NP337752.RA1EYWyjFl08edMONcYPJcwWPmmgQThoa2gsi4TOTIXnk130_provenance.